These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


623 related items for PubMed ID: 24881343

  • 21. Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study.
    Stevenson JC, Durand G, Kahler E, Pertyński T.
    Maturitas; 2010 Nov; 67(3):227-32. PubMed ID: 20688442
    [Abstract] [Full Text] [Related]

  • 22. Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.
    Tane K, Egawa C, Takao S, Yamagami K, Miyashita M, Baba M, Ichii S, Konishi M, Kikawa Y, Minohata J, Okuno T, Miyauchi K, Wakita K, Suwa H, Hashimoto T, Nishino M, Matsumoto T, Hidaka T, Konishi Y, Sakoda Y, Miya A, Kishimoto M, Nishikawa H, Kono S, Kokufu I, Sakita I, Kitatsuji K, Oh K, Akazawa K, Miyoshi Y.
    Breast Cancer; 2017 Jul; 24(4):528-534. PubMed ID: 27730528
    [Abstract] [Full Text] [Related]

  • 23. A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause.
    Archer DF, Bernick BA, Mirkin S.
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):729-739. PubMed ID: 31282768
    [Abstract] [Full Text] [Related]

  • 24. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Vacca F, Genazzani AR.
    Maturitas; 2005 Feb 14; 50(2):91-7. PubMed ID: 15653005
    [Abstract] [Full Text] [Related]

  • 25. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E.
    Menopause; 2009 Feb 14; 16(5):888-91. PubMed ID: 19421076
    [Abstract] [Full Text] [Related]

  • 26. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms.
    Lindh-Astrand L, Bixo M, Hirschberg AL, Sundström-Poromaa I, Hammar M.
    Menopause; 2010 Feb 14; 17(1):72-9. PubMed ID: 19675505
    [Abstract] [Full Text] [Related]

  • 27. Progesterone for treatment of symptomatic menopausal women.
    Prior JC.
    Climacteric; 2018 Aug 14; 21(4):358-365. PubMed ID: 29962247
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
    Cintron D, Lahr BD, Bailey KR, Santoro N, Lloyd R, Manson JE, Neal-Perry G, Pal L, Taylor HS, Wharton W, Naftolin F, Harman SM, Miller VM.
    Menopause; 2018 Feb 14; 25(2):145-153. PubMed ID: 28832429
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
    Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS.
    Menopause; 2006 Feb 14; 13(5):780-6. PubMed ID: 16894334
    [Abstract] [Full Text] [Related]

  • 32. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo S, Collaborative Group for Research of the Climacteric in Latin America (REDLINC).
    Menopause; 2011 Jul 14; 18(7):778-85. PubMed ID: 21407137
    [Abstract] [Full Text] [Related]

  • 33. Practice patterns with hormone therapy after surgical menopause.
    Chubaty A, Shandro MT, Schuurmans N, Yuksel N.
    Maturitas; 2011 May 14; 69(1):69-73. PubMed ID: 21396791
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.
    Cortés-Bonilla M, Bernardo-Escudero R, Alonso-Campero R, Francisco-Doce MT, Hernández-Valencia M, Celis-González C, Márquez-Oñate R, Chedraui P, Uribe JA.
    Gynecol Endocrinol; 2015 Jul 14; 31(7):552-9. PubMed ID: 26062108
    [Abstract] [Full Text] [Related]

  • 36. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS.
    Ann Med; 2010 Jul 14; 42(5):334-43. PubMed ID: 20429800
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.
    Levine DW, Dailey ME, Rockhill B, Tipping D, Naughton MJ, Shumaker SA.
    Psychosom Med; 2005 Jul 14; 67(1):98-104. PubMed ID: 15673630
    [Abstract] [Full Text] [Related]

  • 40. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J, Smetnik VP, Vadász P, Mustonen M, Salminen K, Ylikangas S, Indivina 321 Study Group.
    Menopause Int; 2007 Sep 14; 13(3):116-23. PubMed ID: 17785037
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 32.